@article{2997552,
    title = "Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion",
    author = "Tzartos, J.S. and Valsami, S. and Tzanetakos, D. and Stergiou, C. and Dandoulaki, M. and Barbarousi, D. and Psimenou, E. and Velonakis, G. and Stefanis, L. and Kilidireas, K.",
    journal = "Neurology(R) neuroimmunology & neuroinflammation",
    year = "2020",
    volume = "7",
    number = "3",
    publisher = "NLM (Medline)",
    doi = "10.1212/NXI.0000000000000711",
    keywords = "alemtuzumab;  AQP1 protein, human;  aquaporin 1;  autoantibody;  immunologic factor, adult;  autoimmune hemolytic anemia;  blood;  case report;  human;  immunology;  multiple sclerosis;  myelitis;  recurrent disease, Adult;  Alemtuzumab;  Anemia, Hemolytic, Autoimmune;  Aquaporin 1;  Autoantibodies;  Humans;  Immunologic Factors;  Multiple Sclerosis;  Myelitis, Transverse;  Recurrence"
}